MicroRNA‐193a‐5p exerts a tumor suppressor role in glioblastoma via modulating NOVA1

Glioblastoma (GBM) is the most common and lethal of intracranial tumors, which is characterized by extensive proliferation and the diffused invasion of tumor cells. MicroRNA‐193a‐5p (miR‐193a‐5p) have been demonstrated previously as a functional suppressor in the development and progression of various cancers. The current study aimed to investigate whether miR‐193a‐5p influences cell proliferation and migration through the mitogen‐activated protein kinase/extracellular signal‐regulated kinase signaling pathway by targeting neuro‐oncological ventral antigen 1 (NOVA1) in glioblastoma.

[1]  Xiaoyan Li,et al.  Long Non-Coding RNA Cancer Susceptibility 9 (CASC9) Up-Regulates the Expression of ERBB2 by Inhibiting miR-193a-5p in Colorectal Cancer , 2020, Cancer management and research.

[2]  Yi Pan,et al.  miR-193a-5p promotes pancreatic cancer cell metastasis through SRSF6-mediated alternative splicing of OGDHL and ECM1. , 2020, American journal of cancer research.

[3]  Fan Yang,et al.  MicroRNA-559 plays an inhibitory role in the malignant progression of glioblastoma cells by directly targeting metadherin , 2019, OncoTargets and therapy.

[4]  S. Ju,et al.  Diagnostic Model of Serum miR-193a-5p, HE4 and CA125 Improves the Diagnostic Efficacy of Epithelium Ovarian Cancer , 2018, Pathology & Oncology Research.

[5]  Xin Yu,et al.  NOVA1 acts as an oncogene in melanoma via regulating FOXO3a expression , 2018, Journal of cellular and molecular medicine.

[6]  Man-Li Zhang,et al.  Silencing of miR-193a-5p increases the chemosensitivity of prostate cancer cells to docetaxel , 2017, Journal of experimental & clinical cancer research : CR.

[7]  H. Cui,et al.  Nova1 mediates resistance of rat pheochromocytoma cells to hypoxia-induced apoptosis via the Bax/Bcl-2/caspase-3 pathway , 2017, International journal of molecular medicine.

[8]  Chengzhen Li,et al.  NOVA1 acts as an oncogene in osteosarcoma. , 2017, American journal of translational research.

[9]  Na Hui,et al.  MiR-193a-5p Targets the Coding Region of AP-2α mRNA and Induces Cisplatin Resistance in Bladder Cancers , 2016, Journal of Cancer.

[10]  M. Hsiao,et al.  MiR-193a-5p/ERBB2 act as concurrent chemoradiation therapy response indicator of esophageal squamous cell carcinoma , 2016, Oncotarget.

[11]  S. Cai,et al.  MiR-193a-3p and miR-193a-5p suppress the metastasis of human osteosarcoma cells by down-regulating Rab27B and SRR, respectively , 2016, Clinical & Experimental Metastasis.

[12]  R. Qin,et al.  High expression of WDR1 in primary glioblastoma is associated with poor prognosis. , 2016, American journal of translational research.

[13]  Zhaopei Li,et al.  Icaritin induces apoptotic and autophagic cell death in human glioblastoma cells. , 2016, American journal of translational research.

[14]  Shuo Gu,et al.  Upregulation of microRNA-96 and its oncogenic functions by targeting CDKN1A in bladder cancer , 2015, Cancer Cell International.

[15]  B. Shen,et al.  MicroRNA‐339, an epigenetic modulating target is involved in human gastric carcinogenesis through targeting NOVA1 , 2015, FEBS letters.

[16]  C. Croce,et al.  MicroRNA in Cancer and Cachexia--A Mini-Review. , 2015, The Journal of infectious diseases.

[17]  You-hong Cui,et al.  miR-663 Suppresses Oncogenic Function of CXCR4 in Glioblastoma , 2015, Clinical Cancer Research.

[18]  K. Reddy,et al.  MicroRNA (miRNA) in cancer , 2015, Cancer Cell International.

[19]  Xinjian Zhang,et al.  Impact of Autophagy Inhibition at Different Stages on Cytotoxic Effect of Autophagy Inducer in Glioblastoma Cells , 2015, Cellular Physiology and Biochemistry.

[20]  Xiaowei Wang,et al.  miRDB: an online resource for microRNA target prediction and functional annotations , 2014, Nucleic Acids Res..

[21]  M. Sammeth,et al.  Nova1 is a master regulator of alternative splicing in pancreatic beta cells , 2014, Nucleic acids research.

[22]  P. Zhang,et al.  Downregulation of miR-193a-5p correlates with lymph node metastasis and poor prognosis in colorectal cancer. , 2014, World journal of gastroenterology.

[23]  Juan Li,et al.  Emerging Role of MicroRNAs in Cancer and Cancer Stem Cells , 2014, Journal of cellular biochemistry.

[24]  H. H. Andersen,et al.  MicroRNA Expression Signatures Determine Prognosis and Survival in Glioblastoma Multiforme—a Systematic Overview , 2014, Molecular Neurobiology.

[25]  Jing Zhang,et al.  MicroRNA-155 and MicroRNA-21 Promote the Expansion of Functional Myeloid-Derived Suppressor Cells , 2014, The Journal of Immunology.

[26]  K. Aldape,et al.  Using the molecular classification of glioblastoma to inform personalized treatment , 2014, The Journal of pathology.

[27]  Anders H. Lund,et al.  microRNA-9 targets the long non-coding RNA MALAT1 for degradation in the nucleus , 2013, Scientific Reports.

[28]  Yun Xiao,et al.  Identifying dysfunctional miRNA-mRNA regulatory modules by inverse activation, cofunction, and high interconnection of target genes: a case study of glioblastoma. , 2013, Neuro-oncology.

[29]  S. Chan,et al.  Ineffective delivery of diet-derived microRNAs to recipient animal organisms , 2013, RNA biology.

[30]  S. Ying,et al.  MicroRNA‐mediated somatic cell reprogramming , 2013, Journal of cellular biochemistry.

[31]  Yan Gao,et al.  Dynamic Expression Pattern of Neuro-oncological Ventral Antigen 1 (Nova1) in the Rat Brain after Focal Cerebral Ischemia/Reperfusion Insults , 2013, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[32]  P. Kleihues,et al.  The Definition of Primary and Secondary Glioblastoma , 2012, Clinical Cancer Research.

[33]  J. Fak,et al.  Rescuing Z+ agrin splicing in Nova null mice restores synapse formation and unmasks a physiologic defect in motor neuron firing , 2009, Proceedings of the National Academy of Sciences.

[34]  E. Castigli,et al.  Expression and Modulation of the Intermediate- Conductance Ca2+-Activated K+ Channel in Glioblastoma GL-15 Cells , 2006, Cellular Physiology and Biochemistry.